Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative signaling pathways regulating type I interferon-induced apoptosis.

Katja Pokrovskaja1, Theocharis Panaretakis, Dan Grandér

  • 1Department of Oncology and Pathology, Cancer Center Karolinska (CCK), Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|December 27, 2005
PubMed
Summary

Type I interferons (IFNs) induce apoptosis in tumor cells through various signaling pathways. This review focuses on the molecular mechanisms and noncanonical pathways involved in type I IFN-induced programmed cell death.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment.

Prostate cancer and prostatic diseases·2025
Same author

Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancer.

The oncologist·2024
Same author

Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice.

Cancers·2024
Same author

Body composition as a determinant of the therapeutic index with androgen signaling inhibition.

Prostate cancer and prostatic diseases·2024
Same author

BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression.

Cancer letters·2024

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Type I interferons (IFNs) are crucial cytokines with diverse effects on normal and tumor cells.
  • IFN functions are mediated by signaling pathways, including the canonical Jak-Stat pathway and less-understood PI3K and MAPK pathways.
  • Type I IFNs induce apoptosis, a key mechanism for their anti-cancer effects.

Purpose of the Study:

  • To review recent findings on type I IFN-induced apoptosis.
  • To emphasize the molecular mechanisms underlying this process.
  • To explore the role of alternative signaling pathways in type I IFN-mediated apoptosis.

Main Methods:

  • Literature review of recent studies on type I IFNs and apoptosis.
  • Analysis of molecular mechanisms of apoptosis induction.

Related Experiment Videos

  • Investigation of noncanonical signaling pathways stimulated by type I IFNs.

    • Main Results:

    • Type I IFNs trigger apoptosis through multiple signaling cascades.
    • The canonical Jak-Stat pathway is well-established, but PI3K and MAPK pathways also contribute to IFN effects.
    • Noncanonical pathways play a significant role in mediating type I IFN-induced apoptosis in cancer cells.

    Conclusions:

    • Understanding type I IFN signaling pathways is critical for cancer therapy.
    • Further research into noncanonical pathways may reveal novel therapeutic targets.
    • Type I IFNs hold significant promise as anti-cancer agents through apoptosis induction.